Navigation Links
DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture (EDC) Clinical Trial Survey
Date:6/22/2009

eClinical Forum partners with TechTeam Global to complete important new study

SAN DIEGO, June 22 /PRNewswire-FirstCall/ -- Attendees at the 45th Annual Meeting of the Drug Information Association (DIA), held June 21-25 in San Diego, Calif., will have a chance to respond to an in-depth, global survey of investigational site experience with eClinical trial technologies.

TechTeam Global, Inc. (Nasdaq: TEAM), a worldwide provider of information technology outsourcing and business process outsourcing services, is facilitating the survey in partnership with the eClinical Forum. Members of the eClinical Forum and numerous other collaborating associations have invited site staff involved in clinical trials to participate in this global and system-independent survey. DIA Annual Meeting attendees can participate by visiting Booth 2209 on the conference show floor.

This survey will provide valuable insight into trends regarding use of eClinical technologies. It is the first update in seven years to a report on EDC use in clinical trials published in July 2001. At that time, it was reported that:

  • 52 percent of survey respondents had experience with EDC. Within that group, 44 percent of clinical trials used EDC.
  • The majority of patient data was still entered traditionally in paper patient records, with only 14 percent of data entered directly in electronic case report forms (eCRF).
  • 69 percent of investigators said EDC would positively affect their decision to participate in trials.

Other organizations participating in the 2009 survey include Data Management Biomedical (DMB), Association for Clinical Data Management (ACDM), ARCS Australia Ltd and Der Fachverband fur Berufstatige in der Medizinischen Dokumen
'/>"/>

SOURCE TechTeam Global, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Overview of Pixantrone Phase III Clinical Data Presentation at American Society of Clinical Oncology 2009 Annual Meeting Now Available at Clinical Care Options
2. Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting
3. SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine
4. Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting
5. Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting
6. Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting
7. Proteolix Presents Phase 1b/2 Clinical Data for Carfilzomib in Advanced Solid Tumor Patients at the 2009 ASCO Annual Meeting
8. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
9. Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting
10. Chipscreen and HUYA Bioscience to Present Clinical Data on Novel HDAC Inhibitor at the 2009 ASCO Annual Meeting
11. InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014 Inovio ... successful results from its randomized, double-blind, placebo-controlled ... with biopsy-proven cervical intraepithelial neoplasia 2/3 (CIN2/3) ... or 18. Treatment with VGX-3100, Inovio,s HPV16/18-specific ... to CIN1 or no disease, meeting the ...
(Date:7/23/2014)...  The management team at Columbia Laboratories, Inc. ... conference call on July 31, 2014, to discuss ... 30, 2014.  The call details are as follows:Date: ... EDTDial-in numbers: , Toll free: (877) 870-4263 (U.S.), ... archive): , www.columbialabs.com , under ,Investor, or ...
(Date:7/23/2014)... Global healthcare company GSK reports ... headwinds, increased price competition and supply disruptions to its ... points out that the company is very much in ... be confident about long-term prospects as well as the ... CFO Simon Dingemans adds that the company ...
Breaking Medicine Technology:Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2
... SPRING, Md., June 20, 2011 The U.S. Food ... help advance the development and approval of an artificial ... United States. (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... condition in which the pancreas produces little or no ...
... (NYSE Amex: CUR ) announced that it has ... Phase Ia trial to test the safety of NSI-189 for ... drug in healthy volunteers for safety and tolerability. NSI-189 is ... new neuron growth in the hippocampus, an area of the ...
Cached Medicine Technology:FDA Issues Draft Guidance for Early Version of an Artificial Pancreas System 2FDA Issues Draft Guidance for Early Version of an Artificial Pancreas System 3Neuralstem Updates NSI-189 Major Depression Trial 2Neuralstem Updates NSI-189 Major Depression Trial 3
(Date:7/23/2014)... combining salmon fibrin injections into the spinal cord and ... voluntary motor function impaired by spinal cord injury, scientists ... In a study on rodents, Gail Lewandowski and Oswald ... clock in a molecular pathway critical to the formation ... so that neuronal axons at the injury site could ...
(Date:7/23/2014)... 2014 This report defines and segments ... Europe, the Middle East & Africa, and Americas) - ... geography with analysis and forecasts of the global revenue. ... from over $10 billion in 2014 to nearly $14 ... , browse 49 Market Tables and 10 Figures ...
(Date:7/23/2014)... A Forever Recovery, an open-ended drug ... a great start and gives them a solid foundation ... new Internet Addiction section of its website at ... that Internet addiction is not just as legitimate a ... it’s trapping more and more victims each year – ...
(Date:7/23/2014)... -- Children and teens who lose a parent might face ... new study suggests. People who were children or teens ... of death during the study period than those who had ... report. Although the study found an association between a ... it wasn,t designed to prove cause-and-effect. Also, the increased ...
(Date:7/23/2014)... 2014 SafeUseNow? , a ... developed by Principled Strategies , today announced ... California . Utilizing SafeUseNow’s patent-pending risk model, Partnership ... misusing and abusing controlled substance drugs, particularly prescription ... its members. , The agreement with Partnership HealthPlan ...
Breaking Medicine News(10 mins):Health News:Gene inhibitor, salmon fibrin restore function lost in spinal cord injury 2Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 2Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 3Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 4Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2Health News:Parent's Death May Raise Risk of Early Death for Grown Children, Study Suggests 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 3Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 4
... artists like Ram Kumar, V S Gaitonde and Jehangir ... of contemporary Indian paintings and sculptures held at Durban ... // ,Since having a cultural co-operation between Indian ... between the gallery like Iziko South African National Gallery ...
... painstaking and reaps benefits only when done with full dedication. ... in Georgetown. This has brought to the world the first cancer ... when on June 8, the Food and Drug Administration approved the ... of HPV. ,In the doctor’s own words, "It's a ...
... colleagues at the Indiana University Medical Center, Indianapolis say ... into having unwanted sex //. ,Unwanted sex ... researchers write in the June issue of the Archives ... result in risk for sexually transmitted infections and pregnancies. ...
... inputs on the manner of T-cells enabling immunity and furthering ... will go a long way in measuring the efficiency of ... ,Led by researchers at Beth Israel Deaconess Medical ... National Institute of Allergy and Infectious Diseases (NIAID), part of ...
... leader Sri Sri Ravishankar has said practising yoga, pranayam and ... alcohol abuse. // ,'Youths crave for something different ... dhyan (meditation) to them,' he said while interacting with reporters ... Kundaim, 15 km from here., ,Ravi Shankar appealed to ...
... that secondhand smoking can be deadly. Hence California and Washington laws ... was 58 years old physically fit suffered from heart problems that ... he worked in smoky taverns for 37 years. So the doctors ... to find that the indoor air pollution levels in bars that ...
Cached Medicine News:Health News:Research on AIDS vaccine a wealth of information 2Health News:Research on AIDS vaccine a wealth of information 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: